On March 1, 2023 a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, reported that management will participate in the following upcoming investor conferences (Press release, Jnana Therapeutics, MAR 1, 2023, View Source [SID1234628024]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 43rd Annual Health Care Conference, March 6-8, 2023. Boston Management will participate in one-on-one meetings.
Oppenheimer 33rd Annual Healthcare Conference, March 13-15, 2023 (Virtual). Joanne Kotz, Ph.D., Co-Founder and CEO, will present a company overview at 2:00 p.m. ET on March 15. Management will also participate in one-on-one meetings.